MatchMiner wins the HBS Precision Trials Challenge

We are happy to report that MatchMiner, our computational platform for matching genomic profiles to open clinical trials won 1st place in the Harvard Business School Precision Trials Challenge!

The MatchMiner platform aims to accelerate enrollment in precision medicine clinical trials and maximize clinical trial options for all patients. It is currently being developed in two distinct stages at Dana-Farber, after which point the entire platform will be made fully open source, and available to other institutions. The first stage of the platform is focused on “trial-centric” matching, enabling clinical trial investigators to create individualized genomic filters, and use these filters to forecast clinical trial enrollment, retrospectively identify new patients for clinical trials, and receive alerts of newly sequenced patients matching specific genomic criteria. The second stage of the platform is focused on “patient-centric” matching, enabling any clinician to view matching clinical trials for their specific patient, based on genomic eligibility and real-time clinical trial enrollment slot availability. Stage 1 is now live at Dana-Farber and is currently being used by multiple clinical trial teams.

The Precision Trials Challenge is an online competition to generate ideas on how to bring precision diagnostics and therapies to market faster by reinventing the clinical trials process.

You can view our entry online at HBS. Congrats to the whole team!